Position in SVRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$90,835,008
+$15,812,561 QoQ
Shares Held
14,745,943
+7.3% QoQ
Ownership
7.18%
of shares outstanding
% of Portfolio
2.75%
of 13F equity value
Holder Rank
#3
of 181 holders
Holding Since
Mar 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Venrock Adviser, LLC holds $3,294,790,938 across 31 Biotechnology names. SVRA ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
8,493,321 | $1,127,318,496 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
4,148,428 | $394,805,892 | |
| 3 | ERAS |
Erasca, Inc.
|
17,891,812 | $327,777,995 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
2,985,448 | $265,048,073 | |
| 5 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
1,180,000 | $115,026,400 | |
| 6 | OCUL |
Ocular Therapeutix, Inc
|
10,346,926 | $101,606,813 | |
| 7 | DMRA |
Damora Therapeutics, Inc.
|
3,603,595 | $93,729,505 | |
| 8 | SVRA |
Savara Inc
This page
|
14,745,943 | $90,835,008 |
All Filings in SVRA
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $90,835,008 | 14,745,943 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $75,022,447 | 13,740,375 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $82,854,461 | 13,740,375 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $45,271,323 | 12,681,043 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $20,256,119 | 8,884,263 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,023,660 | 3,257,639 | Shares | Sole | 2025-05-15 | |
| 2023-12-31 | $16,450,000 | 3,500,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $27,158,789 | 7,184,865 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $20,293,141 | 6,351,531 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $12,385,485 | 6,351,531 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,844,873 | 6,351,531 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $7,060,308 | 4,555,038 | Shares | Sole | 2023-05-15 | |
| 2022-06-30 | $6,258,645 | 4,117,530 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $2,495,897 | 1,905,265 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||